Skin Atrophy disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MalaCards based summary: Skin Atrophy, also known as atrophic condition of skin, is related to hallermann-streiff syndrome and mandibuloacral dysplasia with type a lipodystrophy. An important gene associated with Skin Atrophy is FERMT1 (FERM Domain Containing Kindlin 1), and among its related pathways/superpathways are DNA Damage and AP-1 transcription factor network. The drugs Cathine and Guaifenesin have been mentioned in the context of this disorder. Affiliated tissues include skin, breast and tongue, and related phenotypes are growth/size/body region and homeostasis/metabolism

Wikipedia: ⁷⁵ Atrophoderma refers to conditions involving skin... more...

Sources

Related Diseases for Skin Atrophy

Diseases related to Skin Atrophy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 215)

#	Related Disease	Score	Top Affiliating Genes
1	hallermann-streiff syndrome	31.8	ZMPSTE24 GJA1
2	mandibuloacral dysplasia with type a lipodystrophy	31.8	ZMPSTE24 LMNA
3	rothmund-thomson syndrome, type 2	31.7	WRN RECQL4 H2AC18 ERCC6
4	baller-gerold syndrome	31.7	WRN RECQL4 ERCC6
5	werner syndrome	31.4	WRN RECQL4 LMNA
6	telangiectasis	30.3	RECQL4 H2AC18 ERCC6
7	keratosis	30.2	LORICRIN LMNA GJA1 FLG
8	ichthyosis	30.0	LORICRIN GJA1 FLG EBP
9	dermatitis	30.0	LORICRIN IL4 IL31 FLG
10	dermatitis, atopic	29.8	LORICRIN IL4 IL31 FLG
11	calcinosis	29.7	ZMPSTE24 LMNA KL FGF23
12	contact dermatitis	29.7	LORICRIN IL4 IL31 FLG
13	allergic contact dermatitis	29.7	LORICRIN IL4 IL31 FLG
14	cataract	29.5	WRN RECQL4 NR3C1 LMNA KL GJA1
15	skin disease	29.3	RECQL4 LORICRIN IL4 IL31 H2AC18 GJA1
16	atrophoderma of pasini and pierini	11.6
17	atrophoderma vermiculata	11.6
18	bazex syndrome	11.5
19	ichthyosis, congenital, autosomal recessive 11	11.4
20	rombo syndrome	11.4
21	flynn-aird syndrome	11.3
22	keratosis pilaris atrophicans	11.2
23	kindler syndrome	11.1
24	epidermolysis bullosa simplex 6, generalized, with scarring and hair loss	11.1
25	galloway-mowat syndrome 1	11.0
26	x-linked chondrodysplasia punctata 2	11.0
27	xeroderma pigmentosum, variant type	11.0
28	follicular atrophoderma, perioral pigmented, with milia and epidermoid cysts	11.0
29	cutis marmorata telangiectatica congenita	10.8
30	neonatal scleroderma	10.8
31	localized scleroderma	10.4
32	conjunctival deposit	10.3	KL FGF23
33	basal cell carcinoma	10.3
34	rapadilino syndrome	10.3	WRN RECQL4 ERCC6
35	dental abscess	10.3	KL FGF23
36	occupational dermatitis	10.3	IL31 FLG
37	mineral metabolism disease	10.3	KL H2AC18 FGF23
38	hypervitaminosis d	10.2	TRPV5 KL FGF23
39	autosomal recessive cerebellar ataxia	10.2	WRN H2AC18 ERCC6
40	restrictive dermopathy 1	10.2	ZMPSTE24 LMNA
41	cicatricial lagophthalmos	10.2	LORICRIN FLG
42	restrictive dermopathy	10.2	ZMPSTE24 LMNA
43	phosphorus metabolism disease	10.2	TRPV5 KL FGF23
44	bone development disease	10.2	RECQL4 H2AC18 ERCC6
45	hyperostosis	10.2	KL GJA1 FGF23
46	parathyroid gland disease	10.2	TRPV5 KL FGF23
47	lethal restrictive dermopathy	10.2	ZMPSTE24 LMNA
48	lipodystrophy, familial partial, type 1	10.2	ZMPSTE24 LMNA
49	photoparoxysmal response 1	10.2	FERMT1 ERCC6
50	acroosteolysis	10.2	ZMPSTE24 LMNA

Graphical network of the top 20 diseases related to Skin Atrophy:

Sources

Symptoms & Phenotypes for Skin Atrophy

MGI Mouse Phenotypes related to Skin Atrophy:

⁴⁵ (show all 16)

#	Description	MGI Source Accession	Score	Top Affiliating Genes
1	growth/size/body region	MP:0005378	10.37	EBP ERCC6 FERMT1 FGF23 GJA1 IL4
2	homeostasis/metabolism	MP:0005376	10.36	DDIT4 ERCC6 FERMT1 FGF23 GJA1 IL4
3	cellular	MP:0005384	10.25	ACTRT1 DDIT4 ERCC6 FERMT1 GJA1 IL4
4	endocrine/exocrine gland	MP:0005379	10.22	FGF23 GJA1 IL4 KL LMNA LORICRIN
5	renal/urinary system	MP:0005367	10.21	FERMT1 FGF23 IL4 KL LMNA LORICRIN
6	immune system	MP:0005387	10.21	ERCC6 FERMT1 FGF23 GJA1 IL4 KL
7	limbs/digits/tail	MP:0005371	10.19	ERCC6 FGF23 GJA1 IL31 KL LMNA
8	digestive/alimentary	MP:0005381	10.16	FERMT1 FGF23 IL4 KL LMNA NR3C1
9	liver/biliary system	MP:0005370	10.15	ERCC6 IL4 KL LMNA LORICRIN NR3C1
10	adipose tissue	MP:0005375	10.07	ERCC6 KL LMNA NR3C1 TSC22D3 WRN
11	reproductive system	MP:0005389	10.06	ACTRT1 DDIT4 FGF23 GJA1 IL4 KL
12	skeleton	MP:0005390	10.03	ERCC6 FGF23 GJA1 IL31 IL4 KL
13	hematopoietic system	MP:0005397	10	EBP ERCC6 FGF23 GJA1 IL4 KL
14	craniofacial	MP:0005382	9.98	GJA1 IL4 KL LMNA RECQL4 WRN
15	mortality/aging	MP:0010768	9.8	DDIT4 EBP ERCC6 FERMT1 FGF23 GJA1
16	integument	MP:0010771	9.44	EBP ERCC6 FERMT1 FGF23 GJA1 IL4

Sources

Drugs & Therapeutics for Skin Atrophy

Drugs for Skin Atrophy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 20)

#

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

1

Cathine

Approved, Experimental, Illicit, Vet_approved, Withdrawn

Phase 1

14838-15-4, 492-39-7

131954576 4786 26934

2

Guaifenesin

Approved, Investigational, Vet_approved

Phase 1

93-14-1

3516

3

Clobetasol

Approved, Experimental, Investigational

Phase 1

25122-46-7, 25122-41-2

2791 5311051 32798

4

Betamethasone

Approved, Vet_approved

Phase 1

378-44-9

9782

5

Petrolatum

Approved, Investigational

Phase 1

8009-03-8

6

Prasterone

Approved, Investigational, Nutraceutical

Phase 1

53-43-0

5881

7

Chlorpheniramine, phenylpropanolamine drug combination

Phase 1

8

DHEA (Dehydroepiandrosterone)

Phase 1

9

glucocorticoids

Phase 1

10

Hormones

Phase 1

11

Hormone Antagonists

Phase 1

12

Anti-Inflammatory Agents

Phase 1

13

Anti-Asthmatic Agents

Phase 1

14

Betamethasone-17,21-dipropionate

Phase 1

15

Betamethasone Valerate

Phase 1

2152-44-5

16

Betamethasone sodium phosphate

Phase 1

17

Betamethasone benzoate

Phase 1

18

Respiratory System Agents

Phase 1

19

Emollients

Phase 1

20

Dermatologic Agents

Phase 1

Interventional clinical trials:

#	Name	Status	NCT ID	Phase	Drugs
1	A Randomized, Controlled, Observer-blind Psoriasis Plaque Test to Investigate the Anti-psoriatic Efficacy, Tolerability and Safety (Skin Atrophy) of LAS41004 Formulations in Patients With Mild to Moderate Plaque Psoriasis	Completed	NCT02111499	Phase 1, Phase 2	LAS41004-IMP1;LAS41004 IMP2;LAS41004 IMP3;LAS41004 IMP4;LAS41004 IMP6;LAS41004 IMP5
2	An Open, Uncontrolled Pharmacokinetic Study With a New Topical Combination Gel Containing Triiodothyroacetic Acid (TRIAC) and Dehydroepiandrosterone (DHEA) in Subjects With Skin Atrophy Due to Topical Treatment With Glucocorticoids	Unknown status	NCT03783988	Phase 1
3	A Prospective, Randomised, Investigator-Blinded, Vehicle-Controlled, Phase I Clinical Trial With Intra-Individual Comparison of Treatments to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin	Completed	NCT02392130	Phase 1	Clobetasol propionate 0.05% ointment;LEO 130852A gel 1%;LEO 130852A placebo gel
4	A Single-Centre, Explorative, Randomised, Investigator-Blinded, Negative-Controlled, Phase I Clinical Trial With Intra-Individual Comparison of Treatments to Assess Steroid Induced Skin Atrophy on Healthy Skin	Completed	NCT02355639	Phase 1	Clobetasol propionate 0.05 % ointment;Betamethasone dipropionate 0.064 % ointment;Petrolatum ointment

Search NIH Clinical Center for Skin Atrophy

Sources

Genetic Tests for Skin Atrophy

Sources

Anatomical Context for Skin Atrophy

Organs/tissues related to Skin Atrophy:

MalaCards : Skin, Breast, Tongue, Thyroid, Bone, Kidney, Liver

Sources

Publications for Skin Atrophy

Articles related to Skin Atrophy:

(show top 50) (show all 976)

#	Title	Authors	PMID	Year
1	Germline intergenic duplications at Xq26.1 underlie Bazex-Dupré-Christol basal cell carcinoma susceptibility syndrome. ⁶²	Liu Y...Zhang X	35986704	2022
2	Rejuvenation of the ageing face and the role of orthodontics: Guidelines for management. ⁶²	Mavreas D...Athanasiou AE	35437070	2022
3	Kaempferol tetrasaccharides restore skin atrophy via PDK1 inhibition in human skin cells and tissues: Bench and clinical studies. ⁶²	Kim J...Park WS	36252351	2022
4	Efficacy of a triamcinolone acetonide-loaded dissolving microneedle patch for the treatment of hypertrophic scars and keloids: a randomized, double-blinded, placebo-controlled split-scar study. ⁶²	Disphanurat W...Leelawattanachai J	36383222	2022
5	Conradi-Hünermann-Happle syndrome: Clinical and trichoscopic findings. ⁶²	Del Rio-Martinez CJ...Vazquez-Herrera NE	36263758	2022
6	Laser therapy for treating hypertrophic and keloid scars. ⁶²	Leszczynski R...da Silva EM	36161591	2022
7	From Morphea to Dermatofibrosarcoma Protuberans. ⁶²	Crnaric I...Buljan M	36254545	2022
8	Atypical Scleroderma-like Chronic GVHD in a Liver Transplant Patient, Clinical and MRI Correlations. ⁶²	Giannoni M...Offidani A	36254548	2022
9	A plant-derived glucocorticoid receptor modulator with potency to attenuate the side effects of glucocorticoid therapy. ⁶²	Wang Y...Xu Q	36165414	2022
10	Proteomic and miRNA profiling of radon-induced skin damage in mice: FASN regulated by miRNAs. ⁶²	Mo W...Zhang S	35791446	2022
11	Patient preferences for topical psoriasis treatments: a discrete choice experiment. ⁶²	Hoelker S...Schaarschmidt ML	35373695	2022
12	Management of Atopic Dermatitis: The Role of Tacrolimus. ⁶²	Umar BU...Haque M	35990561	2022
13	Conradi-Hünermann-Happle syndrome associated with severe hypocalcemia in a newborn. ⁶²	Dykman M...Boull C	35355312	2022
14	Linear atrophoderma of Moulin is due to the decreased dermal thickness. ⁶²	Zhang LW...Chen T	35687843	2022
15	The mineralocorticoid receptor in skin disease. ⁶²	Perez P	34788475	2022
16	Idiopathic Atrophoderma of Pasini and Pierini: A Case Report and Literature Review. ⁶²	Hubail R...Al Awadhi A	35936167	2022
17	Inhibitory Effect of Mitoxantrone on Collagen Synthesis in Dermal Fibroblasts. ⁶²	Kim KI...Yoon TJ	35721328	2022
18	Isolated and Classic Cutis Marmorata Telangiectatica Congenita ⁶²	Tamburro J...Patel MS	35679444	2022
19	Preclinical Testing of Dendritic Core-Multishell Nanoparticles in Inflammatory Skin Equivalents. ⁶²	Graff P...Hedtrich S	35266720	2022
20	Blaschko-linear lichen planus of the face: A retrospective study of 6 cases and a literature review. ⁶²	Merio L...Petit A	34538651	2022
21	Health benefits of astaxanthin against age-related diseases of multiple organs: A comprehensive review. ⁶²	Alugoju P...Tencomnao T	35708049	2022
22	Stellate Hypopigmentation in a Pediatric Patient After Treatment with Intralesionally-Injected Corticosteroid. ⁶²	Lubov JE...Aranda A	35724245	2022
23	Urological Manifestations of Kindler Syndrome: A Case Report. ⁶²	Ghorai R...Talwar H	35676982	2022
24	Halobetasol Propionate 0.01% Lotion for Plaque Psoriasis and Corticosteroid-Responsive Dermatoses. ⁶²	Abduelmula A...Prajapati VH	35533304	2022
25	Adrenal carcinoma: a case report. ⁶²	Abeynayake DR...Munasinghe TMJ	35637536	2022
26	Reliability of B-mode ultrasound and shear wave elastography in evaluating sacral bone and soft tissue characteristics in young adults with clinical feasibility in elderly. ⁶²	Abou Karam M...Rohan PY	35236613	2022
27	Dermoscopic and Reflectance Confocal Microscopy Features of Superficial Morphea on Preexisting Atrophoderma of Pasini and Pierini. ⁶²	Song CX...Tan C	35646456	2022
28	Efficacy and safety of thermomechanical fractional injury-assisted corticosteroid delivery versus intralesional corticosteroid injection for the treatment of hypertrophic scars: A randomized split-scar trial. ⁶²	Manuskiatti W...Wanitphakdeedecha R	34913497	2022
29	Evaluating topical JAK inhibitors as a treatment option for atopic dermatitis. ⁶²	Fardos MI...Feldman SR	34637367	2022
30	Proactive vs. reactive psoriasis therapy: a long-term evaluation with dermoscopic and confocal microscopy assessment. ⁶²	Cacciapuoti S...Fabbrocini G	35363352	2022
31	Skin atrophy caused by topical glucocorticoids is less common in patients with atopic dermatitis than in those with psoriasis. ⁶²	Lee CH...Choi EH	34351656	2022
32	Novel Dermal Delivery Cargos of Clobetasol Propionate: An Update. ⁶²	Nair AB...Jacob S	35214115	2022
33	Two Cases of Paradoxical Nonscarring Alopecia after Mesotherapy with Dutasteride. ⁶²	Reguero Del Cura L...Gonzalez Lopez MA	35118130	2022
34	Osilodrostat for Cushing disease and its role in pediatrics. ⁶²	Groselj U...Battelino T	35045421	2022
35	Effects of Intermittent Treatment with Topical Corticosteroids and Calcineurin Inhibitors on Epidermal and Dermal Thickness Using Optical Coherence Tomography and Ultrasound. ⁶²	Aschoff R...Koch E	34348352	2022
36	Treatment of a Chronic Vulvar Wound by Hyperbaric Oxygen Therapy (HBOT). ⁶²	Ricard-Gauthier D...Huber DE	35070462	2022
37	Characterization of a novel non-steroidal glucocorticoid receptor agonist optimized for topical treatment. ⁶²	Eirefelt S...Norsgaard H	35087193	2022
38	Linear atrophoderma of Moulin and atrophoderma of Pasini and Pierini: the relevance of ultrasound imaging in the initial assessment. ⁶²	Cozzani EC...Parodi A	31104466	2021
39	Hyperpigmented lesions with acquired atrophy following Blaschko lines in a patient with diagnosed with localized scleroderma. ⁶²	Marin-Hernandez E...Siordia Reyes AG	34594051	2021
40	Pencil Beam Scanning (PBS) Intensity-Modulated Proton Therapy (IMPT) Chemoradiotherapy for Anal Canal Cancer-Single Institution Experience. ⁶²	Vitek P...Rosina J	35008349	2021
41	Novel use of poly-L-lactic acid filler for the treatment of facial cutaneous atrophy in patients with connective tissue disease. ⁶²	Pamatmat JJ...Goff HW	34460983	2021
42	Porokeratosis of the Nail Unit: Case Series and Review. ⁶²	Yendo TM...Nico MMS	34901183	2021
43	Topical steroid containing combinations: Burden of adverse effects and why the recent regulatory action may not be enough. ⁶²	Jhaj R...Sadasivam B	34854405	2021
44	Aesthetic and therapeutic outcome of fat grafting for localized Scleroderma treatment: From basic study to clinical application. ⁶²	Wang HC...Wang X	33486881	2021
45	Acrodermatitis chronica atrophicans: clinical and microbiological characteristics of a cohort of 693 Slovenian patients. ⁶²	Ogrinc K...Strle F	33550695	2021
46	The safety and efficacy of intralesional triamcinolone acetonide for keloids and hypertrophic scars: A systematic review and meta-analysis. ⁶²	Zhuang Z...Wei X	33814214	2021
47	Biorevitalization of the skin with skin boosters: Concepts, variables, and limitations. ⁶²	Arora G...Batra N	33249741	2021
48	The use of high frequency skin ultrasound in non-melanoma skin cancer. ⁶²	Bezugly A...Rembielak A	34484364	2021
49	Hydroxyurea: a reappraisal of its cutaneous side effects and their management. ⁶²	Bulte CA...Khachemoune A	33179784	2021
50	Mucocutaneous manifestations of patients with chronic kidney disease under hemodialysis: A cross-sectional study of 49 patients. ⁶²	Tajalli F...Lakestani D	34080277	2021

Sources

Genes for Skin Atrophy

Genes related to Skin Atrophy (0 elite genes):

(show all 25)

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence
1	FERMT1	FERM Domain Containing Kindlin 1	Protein Coding	22.37	DISEASES inferred ¹⁴ GeneCards inferred via : Disorders Publications (show sections)
2	KL	Klotho	Protein Coding	15.46	DISEASES inferred ¹⁴ GeneCards inferred via : Summaries (show sections)
3	RECQL4	RecQ Like Helicase 4	Protein Coding	12.5	DISEASES inferred ¹⁴ GeneCards inferred via : Disorders (show sections)
4	GJA1	Gap Junction Protein Alpha 1	Protein Coding	10.01	DISEASES inferred ¹⁴ GeneCards inferred via : Disorders (show sections)
5	ERCC6	ERCC Excision Repair 6, Chromatin Remodeling Factor	Protein Coding	8.03	DISEASES inferred ¹⁴ ¹⁴
6	WRN	WRN RecQ Like Helicase	Protein Coding	6.44	DISEASES inferred ¹⁴
7	FGF23	Fibroblast Growth Factor 23	Protein Coding	6.42	DISEASES inferred ¹⁴
8	H2AC18	H2A Clustered Histone 18	Protein Coding	6.1	DISEASES inferred ¹⁴ ¹⁴
9	FLG	Filaggrin	Protein Coding	5.98	DISEASES inferred ¹⁴
10	ACTRT1	Actin Related Protein T1	Protein Coding	5.8	DISEASES inferred ¹⁴
11	NR3C1	Nuclear Receptor Subfamily 3 Group C Member 1	Protein Coding	5.78	DISEASES inferred ¹⁴
12	EBP	EBP Cholestenol Delta-Isomerase	Protein Coding	5.7	DISEASES inferred ¹⁴
13	ZMPSTE24	Zinc Metallopeptidase STE24	Protein Coding	5.61	DISEASES inferred ¹⁴
14	TRPV5	Transient Receptor Potential Cation Channel Subfamily V Member 5	Protein Coding	5.58	DISEASES inferred ¹⁴
15	IL31	Interleukin 31	Protein Coding	5.57	DISEASES inferred ¹⁴
16	TSC22D3	TSC22 Domain Family Member 3	Protein Coding	5.57	DISEASES inferred ¹⁴
17	DDIT4	DNA Damage Inducible Transcript 4	Protein Coding	5.54	DISEASES inferred ¹⁴
18	LMNA	Lamin A/C	Protein Coding	5.51	DISEASES inferred ¹⁴
19	LORICRIN	Loricrin Cornified Envelope Precursor Protein	Protein Coding	5.49	DISEASES inferred ¹⁴
20	IL4	Interleukin 4	Protein Coding	5.47	DISEASES inferred ¹⁴
21	TNF	Tumor Necrosis Factor	Protein Coding	5.47	DISEASES inferred ¹⁴
22	FKBP5	FKBP Prolyl Isomerase 5	Protein Coding	5.44	DISEASES inferred ¹⁴
23	FKBP4	FKBP Prolyl Isomerase 4	Protein Coding	5.43	DISEASES inferred ¹⁴
24	POMC	Proopiomelanocortin	Protein Coding	5.43	DISEASES inferred ¹⁴
25	IGF1	Insulin Like Growth Factor 1	Protein Coding	5.37	DISEASES inferred ¹⁴

Sources

Variations for Skin Atrophy

Sources

Expression for Skin Atrophy

Search GEO for disease gene expression data for Skin Atrophy.

Sources

Pathways for Skin Atrophy

Pathways related to Skin Atrophy according to GeneCards Suite gene sharing:

#	Super pathways	Score	Top Affiliating Genes
1	DNA Damage ³	11.93	WRN RECQL4 LMNA DDIT4
2	AP-1 transcription factor network ⁶¹	10.97	NR3C1 IL4 GJA1
3	Progeria-associated lipodystrophy ⁷⁴ Show member pathways Lamin A-processing pathway ⁷⁴	10.14	ZMPSTE24 WRN LMNA

Sources

GO Terms for Skin Atrophy

Biological processes related to Skin Atrophy according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	positive regulation of gene expression	GO:0010628	9.96	ZMPSTE24 LMNA IL4 GJA1 FGF23 ERCC6
2	telomeric D-loop disassembly	GO:0061820	9.62	WRN RECQL4
3	calcium ion homeostasis	GO:0055074	9.43	TRPV5 KL FGF23
4	neuroinflammatory response	GO:0150076	9.33	NR3C1 IL4
5	positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway	GO:0090080	8.92	KL FGF23

Molecular functions related to Skin Atrophy according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	bubble DNA binding	GO:0000405	9.46	WRN RECQL4
2	four-way junction helicase activity	GO:0009378	9.26	WRN RECQL4
3	telomeric D-loop binding	GO:0061821	8.92	WRN RECQL4

Sources

Sources for Skin Atrophy

¹ BitterDB

² CDC

³ Cell Signaling Technology

⁴ ClinicalTrials

⁵ ClinVar

⁶ CNVD

⁷ Cochrane Library

⁸ Cosmic

⁹ dbSNP

¹⁰ DGIdb

¹¹ Disease Ontology

¹² diseasecard

¹³ DiseaseEnhancer

¹⁴ DISEASES

¹⁵ DrugBank

¹⁶ EFO

¹⁷ ExPASy

¹⁸ FMA

¹⁹ GARD

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ GenomeRNAi

²⁶ GEO DataSets

²⁷ GO

²⁸ GTR

²⁹ HMDB

³⁰ HPO

³¹ ICD10

³² ICD10 via Orphanet

³³ ICD11

³⁴ ICD9CM

³⁵ IUPHAR

³⁶ LifeMap

³⁷ LncRNADisease

³⁸ LOVD

³⁹ MalaCards

⁴⁰ MedGen

⁴¹ MedlinePlus

⁴² MedlinePlus Genetics

⁴³ MeSH

⁴⁴ MESH via Orphanet

⁴⁵ MGI

⁴⁶ miR2Disease

⁴⁷ NCBI Bookshelf

⁴⁸ NCI

⁴⁹ NCIt

⁵⁰ NDF-RT

⁵¹ NIH Clinical Center

⁵² NINDS

⁵³ Novoseek

⁵⁴ Novus Biologicals

⁵⁵ ODiseA

⁵⁶ OMIM via Orphanet

⁵⁷ OMIM® (Updated 08-Dec-2022)

⁵⁸ Orphanet

⁵⁹ PathCards

⁶⁰ PharmGKB

⁶¹ PubChem

⁶² PubMed

⁶³ PubMed Health

⁶⁴ QIAGEN

⁶⁵ R&D Systems

⁶⁶ Reactome

⁶⁷ Sino Biological

⁶⁸ SNOMED-CT

⁶⁹ SNOMED-CT via HPO

⁷⁰ Tocris

⁷¹ UMLS

⁷² UMLS via Orphanet

⁷³ UniProtKB/Swiss-Prot

⁷⁴ WikiPathways

⁷⁵ Wikipedia

MCID: SKN005 MIFTS: 40	Skin Atrophy Categories: Skin diseases	Data Licensing For inquiries, contact: [email protected]
Genes Tissues Related diseases Publications Drugs Expand all tables